Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 12, 2006
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic miceLuke Esposito, Jacob Raber, Lisa Kekonius, et al.
Cell Stem Cell|December 3, 2009
GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin miceGang Li, Nga Bien-Ly, Yaisa Andrews-Zwilling, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 15, 2010
Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in miceYaisa Andrews-Zwilling, Nga Bien-Ly, Qin Xu, et al.
Neurocase|April 20, 2012
ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron diseaseKeith A Vossel, Nga Bien-Ly, Aubrey Bernardo, et al.
The Journal of Biological Chemistry|June 6, 2007
Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse modelsIrene H Cheng, Kimberly Scearce-Levie, Justin Legleiter, et al.
Alzheimer'S Research & Therapy|July 27, 2025
Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's diseaseBalasubrahmanyam Budda, Ananya Mitra, Lovingly Park, et al.
The Journal of Experimental Medicine|January 29, 2014
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variantsNga Bien-Ly, Y Joy Yu, Daniela Bumbaca, et al.
Neuron|October 24, 2015
Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic AntibodiesNga Bien-Ly, C Andrew Boswell, Surinder Jeet, et al.
Neuron|September 6, 2007
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's diseaseJorge J Palop, Jeannie Chin, Erik D Roberson, et al.
Science Translational Medicine|February 18, 2021
APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular functionMonica Xiong, Hong Jiang, Javier Remolina Serrano, et al.
Pageof 3